Deals

Biotech

Ikena, after tough year of layoffs, merges with Inmagene

After a year that saw Ikena trim its workforce and pipeline, the oncology biotech thinks it’s found a path forward via a merger into Inmagene.

James Waldron Dec 23, 2024 10:00am

compass map direction find trail north

Rapt pays $35M for challenger to Novartis, Roche drug

Dec 23, 2024 8:10am

Sanofi

Sanofi pays SK $52M as children's pneumococcal shot enters ph. 3

Dec 23, 2024 8:05am

scoop of pink ice cream

Sanofi scoops up China rights to Cytokinetics' heart disease med

Dec 20, 2024 11:07am

Graphic image of a pen signing a signature while two strangelooking business people cheer

Oncology biotech licenses Genevant tech for up to $123M

Dec 20, 2024 6:00am

team layoffs workforce

Idorsia's Tryvio sale behind schedule, but layoffs on track

Dec 20, 2024 4:42am